WallStreetZenWallStreetZen

NYSE: MED
Medifast Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for MED

Based on 2 analysts offering 12 month price targets for Medifast Inc.
Min Forecast
$150.00+36.8%
Avg Forecast
$214.00+95.17%
Max Forecast
$278.00+153.53%

Should I buy or sell MED stock?

Based on 2 analysts offering ratings for Medifast Inc.
Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MED stock forecasts and price targets.

MED stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
DA Davidson
Bottom 18%
18
Strong BuyMaintains$278.00+153.53%2022-08-04
Jefferies
Top 21%
80
HoldDowngrades$150.00+36.80%2022-08-04

1 of 1

Forecast return on equity

Is MED forecast to generate an efficient return?
Company
N/A
Industry
181.57%
Market
118.31%

Forecast return on assets

Is MED forecast to generate an efficient return on assets?
Company
N/A
Industry
5.69%

MED earnings per share forecast

What is MED's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$11.94-12.14%
Avg 2 year Forecast
$13.36-1.69%
MED's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

MED revenue forecast

What is MED's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.5B-7.36%
Avg 2 year Forecast
$1.5B-10.74%
Avg 3 year Forecast
$1.3B-19.73%
MED's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MED earnings growth forecast

How is MED forecast to perform vs Personal Services companies and vs the US market?
Company
2.84%
Industry
10.15%
Market
16.45%
MED's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
MED's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
MED's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

MED revenue growth forecast

How is MED forecast to perform vs Personal Services companies and vs the US market?
Company
-6.71%
Industry
3.37%
Market
8.47%
MED's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MED's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MED vs Personal Service Stocks

TickerPricePrice TargetUp/downsideConsensus
MED$109.65$214.00+95.17%Buy
FRG$26.24$53.00+101.98%Strong Buy
DSEY$4.88$11.70+139.75%Buy
FTDR$20.52$33.17+61.63%Hold
ROVR$3.23$6.29+94.61%Buy

Medifast Stock Forecast FAQ

Is Medifast Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSE: MED) stock is to Buy MED stock.

Out of 2 analysts, 1 (50%) are recommending MED as a Strong Buy, 0 (0%) are recommending MED as a Buy, 1 (50%) are recommending MED as a Hold, 0 (0%) are recommending MED as a Sell, and 0 (0%) are recommending MED as a Strong Sell.

If you're new to stock investing, here's how to buy Medifast stock.

What is MED's earnings growth forecast for 2022-2023?

(NYSE: MED) Medifast's forecast annual earnings growth rate of 2.84% is not forecast to beat the US Personal Services industry's average forecast earnings growth rate of 10.15%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.45%.

Medifast's earnings in 2022 is $156,899,000.On average, 2 Wall Street analysts forecast MED's earnings for 2022 to be $131,553,714, with the lowest MED earnings forecast at $122,849,574, and the highest MED earnings forecast at $140,368,033.

In 2023, MED is forecast to generate $147,199,131 in earnings, with the lowest earnings forecast at $123,951,364 and the highest earnings forecast at $170,336,719.

What is MED's revenue growth forecast for 2022-2024?

(NYSE: MED) Medifast's forecast annual revenue growth rate of -6.71% is not forecast to beat the US Personal Services industry's average forecast revenue growth rate of 3.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.47%.

Medifast's revenue in 2022 is $1,662,162,000.On average, 1 Wall Street analysts forecast MED's revenue for 2022 to be $16,966,462,670, with the lowest MED revenue forecast at $16,966,462,670, and the highest MED revenue forecast at $16,966,462,670. On average, 1 Wall Street analysts forecast MED's revenue for 2023 to be $16,346,154,956, with the lowest MED revenue forecast at $16,346,154,956, and the highest MED revenue forecast at $16,346,154,956.

In 2024, MED is forecast to generate $14,700,080,846 in revenue, with the lowest revenue forecast at $14,700,080,846 and the highest revenue forecast at $14,700,080,846.

What is MED's forecast return on assets (ROA) for 2022-2025?

(NYSE: MED) forecast ROA is N/A, which is lower than the forecast US Personal Services industry average of 5.69%.

What is MED's Price Target?

According to 2 Wall Street analysts that have issued a 1 year MED price target, the average MED price target is $214.00, with the highest MED stock price forecast at $278.00 and the lowest MED stock price forecast at $150.00.

On average, Wall Street analysts predict that Medifast's share price could reach $214.00 by Aug 4, 2023. The average Medifast stock price prediction forecasts a potential upside of 95.17% from the current MED share price of $109.65.

What is MED's Earnings Per Share (EPS) forecast for 2022-2023?

(NYSE: MED) Medifast's current Earnings Per Share (EPS) is $13.59. On average, analysts forecast that MED's EPS will be $11.94 for 2022, with the lowest EPS forecast at $11.15, and the highest EPS forecast at $12.74. In 2023, MED's EPS is forecast to hit $13.36 (min: $11.25, max: $15.46).

What is MED's forecast return on equity (ROE) for 2022-2025?

(NYSE: MED) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.